Significant progress has been made in the treatment of chronic lymphocytic leukemia (CLL) patients during the last two decades. In this review we present a personal case study for discussion on contemporary management in CLL. Presently immunochemotherapy using fludarabine, cyclophosphamide, and rituximab...
Carolyn Owen, MD, associate professor in the Division of Hematology & Hematological Malignancies, University of Calgary, and hematologist at the Tom Baker Cancer Center, discusses how the treatment landscape has shifted in chronic lymphocytic leukemia (CLL). ...
Acute myeloid leukemia (AML) also known as acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, and acute non-lymphocytic leukemia.
Acute lymphoblastic leukemia(ALL), also called acute lymphocytic leukemia. ALL accounts for 3 out of every 4 cases of childhood leukemia. Acute myelogenous leukemia(AML). AML is the next most common type of childhood leukemia. Hybrid or mixed lineage leukemia. This is a rare leukemia with featu...
Dr Mitchell Horwitz sheds light on ibrutinib, emphasizing its efficacy in chronic lymphocytic leukemia. He underscores its unique ability to target both B-cell and T-cell pathways, offering a dual mechanism against chronic GVHD. Dr Corey Cutler introduces belumosudil, a ROCK2 inhibitor, explaining...
June 2018 – Venetoclaxwas approved for chronic lymphocytic leukemia (CLL) patients, with or without 17p deletion, who have received at least one prior therapy. May 2018 – Tisagenlecleucel (Kymriah)was approved for treatment of people with relapsed/refractory large B-cell lymphoma who have rec...
Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 1991; 325: 81–6 Article PubMed CAS Google Scholar Download references Author information Authors and Affiliations Department of Gastroenterology, Azienda Ospedaliera Careggi, viale Morgagni 85, ...
B-cell lymphomas include diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, marginal zone B-cell lymphoma, Burkitt lymphoma, Waldenstrom macroglobulinemia, hairy cell leukemia, and primary central nervous system lymphoma. On the other hand, T-cell no...
ALL indicates acute lymphoid leukemia; AML,acute myeloid leukemia; B-ALL, B-cell acute lymphocytic leukemia; CLL, chronic lymphoid leukemia; and CML, chronic myeloid leukemia. The 4 main subtypes of leukemia can be differentiated based on occurrences, prognosis, and outcomes. ...
Chronic Lymphocytic LeukemiaHematologic OncologyNon-Hodgkin Lymphoma January 12th 2025 BTK Degraders Look to Fill Unmet Need for Patients With Pretreated B-Cell Malignancies November 29th 2024 FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL January 10th 2025 Venetoclax Plus BTK Inhibitor–Based...